3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
2
Thyroid Neoplasms
1
Thoracic Neoplasms
1
Solid Tumors
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Neoplasms, Nerve Tissue
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Lung Diseases
1
Head and Neck Neoplasms
1
Carcinoma, Bronchogenic
1
Carcinoma
1
Bronchial Diseases
1
Advanced Thyroid Cancer Patients Who Received Target Therapy
1
Adenocarcinoma
1
Interventions
Carboplatin
3
selpercatinib
2
pembrolizumab
2
durvalumab
2
Radiosurgery
2
Pemetrexed
2
Cisplatin
2
sotorasib
1
repotrectinib
1
ceralasertib
1
cemiplimab
1
capmatinib
1
aflutinib
1
Toll-Like Receptor 1
1
Platinum Compounds
1
Paclitaxel
1
Gemcitabine
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bronchial Neoplasms
×
pralsetinib
×
1 year
×
Clear all
No trials found.